Company profile
Cimeio Therapeutics
Reinventing cell therapy through our leadership in the emerging field of epitope shielding
- Industry
- Biotechnology Research
- Employees
- 16
- Headquarters
- Cambridge, MA
- Founded
- 2020
- LinkedIn followers
- 4,100
- Office locations
- 2
Cimeio Therapeutics company summary
Cimeio Therapeutics is a company in the Biotechnology Research industry, headquartered in Cambridge, MA, founded in 2020. On LinkedIn the company has around 16 employees and 4,100 followers. The company lists 2 office locations.
What technology does Cimeio Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Cimeio Therapeutics
Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases. Cimeio’s proprietary technology platform is based on the discovery of protein variants, which when edited into cells allow them to maintain full function while resisting paired immunotherapy depletion. This technology has significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with genetic diseases, hematologic malignancies, and severe autoimmune disorders.
Where is Cimeio Therapeutics located?
Cimeio Therapeutics lists 2 office locations.
Compare companies similar to Cimeio Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Cimeio Therapeutics cimeio.com | Biotechnology Research | 16 | 2020 | Cambridge, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Cimeio Therapeutics
What does Cimeio Therapeutics do?
Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases. Cimeio’s proprietary technology platform is based on the discovery of protein variants, which when edited into cells allow them to maintain full function while resisting paired immunotherapy depletion. This technology has significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with genetic diseases, hematologic malignancies, and severe autoimmune disorders.
How many employees does Cimeio Therapeutics have?
Cimeio Therapeutics has around 16 employees on LinkedIn.
Where is Cimeio Therapeutics headquartered?
Cimeio Therapeutics is headquartered in Cambridge, MA.
Where does Cimeio Therapeutics have offices?
Cimeio Therapeutics lists 2 office locations, including Cambridge, MA, US; Basel, CH, CH.
When was Cimeio Therapeutics founded?
Cimeio Therapeutics was founded in 2020.
Build a lead list from companies like Cimeio Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.